Ardelyx (ARDX) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59% |
| Dec 31, 2025 | 5.77% |
| Sep 30, 2025 | 3.27% |
| Jun 30, 2025 | -0.95% |
| Mar 31, 2025 | -2.78% |
| Dec 31, 2024 | -1.48% |
| Sep 30, 2024 | 26.35% |
| Jun 30, 2024 | 16.46% |
| Mar 31, 2024 | 10.44% |
| Dec 31, 2023 | 7.57% |
| Sep 30, 2023 | 6.21% |
| Jun 30, 2023 | -5.50% |
| Mar 31, 2023 | -0.56% |
| Dec 31, 2022 | -6.73% |
| Sep 30, 2022 | -11.99% |
| Jun 30, 2022 | -18.22% |
| Mar 31, 2022 | -17.47% |
| Dec 31, 2021 | -15.62% |
| Sep 30, 2021 | -18.24% |
| Jun 30, 2021 | -3.52% |
| Mar 31, 2021 | -4.85% |
| Dec 31, 2020 | 2.98% |
| Sep 30, 2020 | 0.97% |
| Jun 30, 2020 | 0.57% |
| Mar 31, 2020 | 23.67% |
| Dec 31, 2019 | 25.20% |
| Sep 30, 2019 | -4.93% |
| Jun 30, 2019 | 1.77% |
| Dec 31, 2018 | 30.77% |